HULTA PHARMA | SURAJ ESTATE DEVELOPERS LTD. | HULTA PHARMA/ SURAJ ESTATE DEVELOPERS LTD. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -15.4 | - | - | View Chart |
P/BV | x | - | 23.6 | - | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
HULTA PHARMA Mar-23 |
SURAJ ESTATE DEVELOPERS LTD. Mar-23 |
HULTA PHARMA/ SURAJ ESTATE DEVELOPERS LTD. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 10 | NA | - | |
Low | Rs | 3 | NA | - | |
Sales per share (Unadj.) | Rs | 0 | 96.3 | 0.0% | |
Earnings per share (Unadj.) | Rs | -0.4 | 10.1 | -4.2% | |
Cash flow per share (Unadj.) | Rs | -0.4 | 10.9 | -3.9% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | -1.2 | 22.5 | -5.3% | |
Shares outstanding (eoy) | m | 7.45 | 31.75 | 23.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0 | 0 | - | |
Avg P/E ratio | x | -15.7 | 0 | - | |
P/CF ratio (eoy) | x | -15.7 | 0 | - | |
Price / Book Value ratio | x | -5.6 | 0 | - | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 50 | 0 | - | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1 | 116 | 0.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 0 | 3,057 | 0.0% | |
Other income | Rs m | 0 | 21 | 0.0% | |
Total revenues | Rs m | 0 | 3,079 | 0.0% | |
Gross profit | Rs m | -3 | 1,510 | -0.2% | |
Depreciation | Rs m | 0 | 26 | 0.0% | |
Interest | Rs m | 1 | 1,074 | 0.1% | |
Profit before tax | Rs m | -3 | 432 | -0.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 111 | 0.0% | |
Profit after tax | Rs m | -3 | 321 | -1.0% | |
Gross profit margin | % | 0 | 49.4 | - | |
Effective tax rate | % | 0 | 25.8 | -0.0% | |
Net profit margin | % | 0 | 10.5 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 0 | 8,917 | 0.0% | |
Current liabilities | Rs m | 0 | 5,197 | 0.0% | |
Net working cap to sales | % | 0 | 121.7 | - | |
Current ratio | x | 3.6 | 1.7 | 211.9% | |
Inventory Days | Days | 0 | 38 | - | |
Debtors Days | Days | 0 | 135 | - | |
Net fixed assets | Rs m | 0 | 473 | 0.1% | |
Share capital | Rs m | 75 | 159 | 46.9% | |
"Free" reserves | Rs m | -83 | 555 | -15.0% | |
Net worth | Rs m | -9 | 714 | -1.3% | |
Long term debt | Rs m | 10 | 3,457 | 0.3% | |
Total assets | Rs m | 1 | 9,391 | 0.0% | |
Interest coverage | x | -4.8 | 1.4 | -342.2% | |
Debt to equity ratio | x | -1.1 | 4.8 | -22.1% | |
Sales to assets ratio | x | 0 | 0.3 | 0.0% | |
Return on assets | % | -361.5 | 14.8 | -2,435.0% | |
Return on equity | % | 35.6 | 44.9 | 79.3% | |
Return on capital | % | -425.6 | 36.1 | -1,179.2% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -3 | 1,885 | -0.2% | |
From Investments | Rs m | NA | -271 | -0.0% | |
From Financial Activity | Rs m | 3 | -1,557 | -0.2% | |
Net Cashflow | Rs m | 0 | 57 | -0.1% |
Indian Promoters | % | 0.0 | 75.0 | - | |
Foreign collaborators | % | 56.3 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.1 | 8.8 | 12.2% | |
FIIs | % | 0.0 | 5.7 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 43.7 | 25.1 | 174.4% | |
Shareholders | 3,820 | 59,301 | 6.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare HULTA PHARMA With: DLF DB REALTY PHOENIX MILL PRESTIGE ESTATES PSP PROJECTS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | HULTA PHARMA | SURAJ ESTATE DEVELOPERS LTD. | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 4.86% | 3.97% | 0.45% |
1-Month | -15.75% | 44.01% | 2.55% |
1-Year | 58.32% | 13.69% | 56.14% |
3-Year CAGR | 24.48% | 4.37% | 15.22% |
5-Year CAGR | 0.53% | 2.60% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the HULTA PHARMA share price and the SURAJ ESTATE DEVELOPERS LTD. share price.
Moving on to shareholding structures...
The promoters of HULTA PHARMA hold a 56.3% stake in the company. In case of SURAJ ESTATE DEVELOPERS LTD. the stake stands at 75.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of HULTA PHARMA and the shareholding pattern of SURAJ ESTATE DEVELOPERS LTD..
Finally, a word on dividends...
In the most recent financial year, HULTA PHARMA paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
SURAJ ESTATE DEVELOPERS LTD. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of HULTA PHARMA, and the dividend history of SURAJ ESTATE DEVELOPERS LTD..
For a sector overview, read our pharmaceuticals sector report.
Indian share markets reversed the trend as the session progressed and ended the lower. After starting higher on Friday, equity markets had an anti-climatic end today.